Medroxyprogesterone acetate in the management of cancer cachexia. - Wikidata - wikimedia - TriplyDB

Medroxyprogesterone acetate in the management of cancer cachexia.

Medroxyprogesterone acetate in the management of cancer cachexia.

http://www.wikidata.org/entity/Q34607739

about

Combination of imatinib mesylate with lithium chloride and medroxyprogesterone acetate is highly active in Ishikawa endometrial carcinoma in vitro.Citrus unshiu peel extract alleviates cancer-induced weight loss in mice bearing CT-26 adenocarcinoma.Drugs in development for treatment of patients with cancer-related anorexia and cachexia syndrome.Targeted therapies for renal cell carcinoma: review of adverse event management strategies.Current pharmacotherapy options for cancer anorexia and cachexia.Cancer cachexia syndrome: pathogenesis, diagnosis, and new therapeutic options.Cachexia in patients with oesophageal cancer.

P2860

Q35663624-A813B6B1-C661-4669-8000-454F074C620C Q36785320-6B13B882-9B30-4BB1-9E24-755CB1ACA847 Q37103603-E9121053-C60A-429C-B0C8-FC595697974F Q37974894-A3D08226-2A09-4E08-A411-B2E83967286A Q38052613-C1C7AD42-ABCA-4363-9F54-997620AB2EA2 Q38290238-BAF897C8-DB4B-45EB-938A-0FD45908BCF6 Q38634739-F2B66C23-FB2C-486E-96BE-624427D3D4AE

P2860

Medroxyprogesterone acetate in the management of cancer cachexia.

http://www.wikidata.org/entity/Q34607739

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Medroxyprogesterone acetate in the management of cancer cachexia.

@ast

Medroxyprogesterone acetate in the management of cancer cachexia.

@en

Medroxyprogesterone acetate in the management of cancer cachexia.

@nl

type

label

Medroxyprogesterone acetate in the management of cancer cachexia.

@ast

Medroxyprogesterone acetate in the management of cancer cachexia.

@en

Medroxyprogesterone acetate in the management of cancer cachexia.

@nl

prefLabel

Medroxyprogesterone acetate in the management of cancer cachexia.

@ast

Medroxyprogesterone acetate in the management of cancer cachexia.

@en

Medroxyprogesterone acetate in the management of cancer cachexia.

@nl

P1433

Q34607739-62D2F775-A861-4DFD-A070-01795D91BA2C

P1476

Q34607739-7E75B683-1979-495F-8725-4EDEFF4C7C0D

P2093

Q34607739-8D2D0CA4-D73D-47E4-ABC2-1BB1565885DA

Q34607739-922131D5-E344-47B5-B68E-84B43092F0EA

Q34607739-92B45686-5461-49A7-B0A2-C2C1197A6003

Q34607739-B005A78E-F6FF-48C1-AEF2-7F16A7D39DF6

Q34607739-FEC5A762-2C6D-4903-892E-7F3173619D53

P2860

Q34607739-01831720-87B1-4EBD-864A-B1EDCDD368D7

Q34607739-02E5100E-92AA-4DB3-B85E-2A913E836332

Q34607739-0A172B0D-F67A-4458-BD67-AC0BF92F0052

Q34607739-0A3C7DC3-40B3-44C1-98F4-D0E479F4645B

Q34607739-0D3528EC-ECEF-4BBD-8658-16570C02EE98

Q34607739-2D0C087A-4359-42EF-AE6B-1D265367256D

Q34607739-30B53AD4-BC1D-4B84-B98A-4663167AD374

Q34607739-33EE2920-61F1-443B-A6D7-6773DCF5D98E

Q34607739-45C4DE35-03E7-4C58-8F61-5714A796D7F4

Q34607739-53C1B870-0CAA-46B9-8486-C6EB9385ABCF

P304

Q34607739-F9D6BA59-C601-4BC6-9B41-FE228A9E2CD9

P31

Q34607739-729D314E-0AFD-4E4D-914B-A5D546B127C9

P356

Q34607739-CE376E33-5D24-41EC-B98D-A69F9714365B

P407

Q34607739-9BF6F72E-EAF5-43F8-8B9E-CAF770E5ADC5

P433

Q34607739-785A169F-A119-4096-BD8E-7547099B508E

P478

Q34607739-8755892C-0CFF-4215-9E09-2582E30355E6

P577

Q34607739-FBBAA9B0-FBE2-4611-BACF-F0DB9D647334

P698

Q34607739-97D3A462-AB39-4C80-83B5-7B16C6F8F27A

P356

14656560902960162

P1433

Expert Opinion on Pharmacotherapy

P1476

Medroxyprogesterone acetate in the management of cancer cachexia.

@en

P2093

Antonio Macciò

http://www.w3.org/2001/XMLSchema#string

Clelia Madeddu

http://www.w3.org/2001/XMLSchema#string

Filomena Panzone

http://www.w3.org/2001/XMLSchema#string

Francesca Maria Tanca

http://www.w3.org/2001/XMLSchema#string

Giovanni Mantovani

http://www.w3.org/2001/XMLSchema#string

P2860

Classification and pharmacology of progestins

The role of TNF alpha in adipocyte metabolism.

High-dose progestins for the treatment of cancer anorexia-cachexia syndrome: a systematic review of randomised clinical trials.

Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes.

Randomized phase III clinical trial of five different arms of treatment for patients with cancer cachexia: interim results.

Cachexia: a new definition.

Medroxyprogesterone acetate and cancer cachexia: interleukin-6 involvement.

A review of the drug treatment of cachexia associated with cancer.

Managing cancer-related anorexia/cachexia.

Pharmacological profile of progestins.

P304

1359-1366

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14656560902960162

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2009-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19445562

http://www.w3.org/2001/XMLSchema#string